Skip to main content

Advertisement

SpringerLink
Log in

SEOM clinical guidelines for the treatment of early breast cancer

  • Clinical Guides in Oncology
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

The incidence is increasing due to mammographic screening and an ageing population. In some countries the mortality rate has decreased especially in middleaged and younger groups because of improved treatment and possibly earlier detection. However, breast cancer is still the leading cause of cancer-related death in European women. The purpose of this work was to elaborate a Spanish Society of Medical Oncology guideline on pharmacologic interventions for early breast cancer (BC). We have compiled the latest advances in the management of this pathology either in the adjuvant and neoadjuvant setting, cytostatic and hormonal treatment, so that in a simple way could be useful to oncologist, residents and other related specialties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  Google Scholar 

  2. Albanell J, Alvarez I, Barnadas A et al (2007) Consenso en el tratamiento hormonal adyuvante del cáncer de mama de pacientes premenopáusicas. Curr Opin Oncol 19:S25–S35

    Google Scholar 

  3. Goldhirsch A, Wood WC, Gelber RD et al and panel members (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133–1144

    Article  CAS  PubMed  Google Scholar 

  4. Mamounas EP, Bryant J, Lembersky B et al (2005) Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for nodepositive breast cancer: result from NSABP B-28. J Clin Oncol 23:3686–3696

    Article  CAS  PubMed  Google Scholar 

  5. Martin M, Pienkowski T, Mackey J et al (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302–2313

    Article  CAS  PubMed  Google Scholar 

  6. Jones SE, Savin MA, Holmes FA et al (2006) Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer. J Clin Oncol 24:5381–5387

    Article  CAS  PubMed  Google Scholar 

  7. Martin M, Rodriguez-Lescure A, Ruiz A et al (2008) Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer. J Natl Cancer Inst 100:805–814

    Article  CAS  PubMed  Google Scholar 

  8. Viani GA, Afonso SL, Stefano EJ et al (2007) Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials. BMC Cancer 7:153

    Article  PubMed  Google Scholar 

  9. Mauri D, Pavlidis N, Ioannidis JP (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97:188–195

    Article  PubMed  Google Scholar 

  10. Smith IE, Dowsett M, Ebbs SR (2005) Neoadjuvant treatment for postmenopausal breast cancer with anastrozole, tamoxifen or both in combination: the Inmediate Preoperative Anastrozol, Tamoxifen or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. J Clin Oncol 23:5108–5116

    Article  CAS  PubMed  Google Scholar 

  11. Buzdar AU, Valero V, Ibrahim NK (2007) Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer. Clin Cancer Res 13:228–233

    Article  CAS  PubMed  Google Scholar 

  12. Bear HD, Anderson S, Smith RE (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24:2019–2027

    Article  CAS  PubMed  Google Scholar 

  13. Green MC, Buzdar AU, Smith T (2005) Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every three weeks. J Clin Oncol 23:5983–5992

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Oncología Médica, Instituto Catalán de Oncologia (ICO), Hospital Dr. Josep Trueta, Avda. Francia, s/n, ES-17005, Gerona, Spain

    Sonia del Barco Berrón

  2. Servicio de Oncología Médica, Hospital Universitario, 12 de Octubre, Madrid, Spain

    Eva Ciruelos Gil

  3. Servicio de Oncología Médica, Hospital del Mar, Barcelona, Spain

    Ignacio Tusquets Trías de Bes

  4. Servicio de Oncología Médica, Hospital Clinic i Provincial, Barcelona, Spain

    Montserrat Muñoz Mateu

  5. Servicio de Oncología Médica, Complejo Hospitalario Universitario, Jaén, Spain

    Pedro Sánchez Rovira

  6. Servicio de Oncología Médica, Hospital General Universitario de Elche, Elche Alicante, Spain

    Álvaro Rodríguez Lescure

  7. Servicio de Oncología Médica, Hospital Clínico Universitario, Lozano Blesa Zaragoza, Spain

    Dolores Isla Casado

Authors
  1. Sonia del Barco Berrón
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Ciruelos Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ignacio Tusquets Trías de Bes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Montserrat Muñoz Mateu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pedro Sánchez Rovira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Álvaro Rodríguez Lescure
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dolores Isla Casado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sonia del Barco Berrón.

Additional information

Supported by an unrestricted educational grant from MSD Oncology

Rights and permissions

Reprints and permissions

About this article

Cite this article

del Barco Berrón, S., Ciruelos Gil, E., Tusquets Trías de Bes, I. et al. SEOM clinical guidelines for the treatment of early breast cancer. Clin Transl Oncol 12, 711–718 (2010). https://doi.org/10.1007/s12094-010-0584-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-010-0584-7

Keywords

Search

Navigation